drugset
drugset / Trial / NCT04222725

A Study of TRS01 in Participants With Post-surgical Ocular Inflammation

NCT04222725 ↗

Phase 1/2 Completed 37 enrolled Tarsier Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate the safety and preliminary efficacy of TRS01 eye drops as compared to placebo on participants with ocular inflammation after cataract surgery.

Timeline

Start
2020-02-01
Primary completion
2020-07-17
Completion
2020-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject dazdotuftide Small molecule — Other

Indications

No indication recorded.